CEO and Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS, Financial) Fuad El-hibri sells 25,000 shares of EBS on 04/29/2010 at an average price of $16.53 a share.
Emergent Biosolutions Inc. has a market cap of $511.3 million; its shares were traded at around $16.57 with a P/E ratio of 15.7 and P/S ratio of 2.2.
EBS is in the portfolios of Chuck Royce of Royce& Associates, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC, Manning & Napier Advisors, Inc.
Emergent Biosolutions Inc. has a market cap of $511.3 million; its shares were traded at around $16.57 with a P/E ratio of 15.7 and P/S ratio of 2.2.
EBS is in the portfolios of Chuck Royce of Royce& Associates, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC, Manning & Napier Advisors, Inc.
CEO Recent Trades:
- Sell:: CEO and Chairman, 10% Owner Fuad El-hibri sold 900 shares of EBS stock on 04/21/2010 at the average price of 16, the price of the stock has increased by 3.56% since.
- Sell:: CEO and Chairman, 10% Owner Fuad El-hibri sold 17,600 shares of EBS stock on 04/15/2010 at the average price of 16.02, the price of the stock has increased by 3.43% since.
- Sell:: CEO and Chairman, 10% Owner Fuad El-hibri sold 6,500 shares of EBS stock on 04/12/2010 at the average price of 16.08, the price of the stock has increased by 3.05% since.
Directors and Officers Recent Trades:
- Sell:: Director Jerome M Hauer sold 20,000 shares of EBS stock on 03/09/2010 at the average price of 15.82, the price of the stock has increased by 4.74% since.
